Horsham: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved TREMFYA (guselkumab) ...

Union Health Minister JP Nadda on Monday informed that nine lakh health camps have been held across the country under the ...

In 2023, the groundbreaking Australian BANDIT (Baricitinib in New Onset Type 1 Diabetes) trial reported that a daily pill of ...

65% of patients with end-stage renal disease (ESRD) exhibited proliferative diabetic retinopathy (PDR), the most advanced ...

A new study published in the Frontiers in Cardiovascular Medicine showed that wearable technology for monitoring pulmonary ...

A new study has found that prompt administration of opioid pain relief in emergency departments reduces the likelihood of ...

The Union Health Ministry is now examining the issue of the National Medical Commission (NMC) rejecting appeals by ...

Noting the fact that the reduction in GST rates (18% to 5%, 12% to 0%, 12% to 5%) has benefited consumers, but it has ...

Zydus Lifesciences Limited has informed the stock exchanges that the Commissioner of Central Goods and Services Tax (CGST), ...

The US government's recent decision to impose a 100 percent tariff on imports of branded and patented pharmaceutical products ...

The Subject Expert Committee (SEC) functioning under the Central Drugs Standard Control Organisation (CDSCO) has granted ...

The Supreme Court of India has issued notices to top government officials in response to a contempt plea alleging ...